Biotech · Public company · Fort Lauderdale, FL, US

Alaunos Therapeutics, Inc.

Ticker TCRT · SEC CIK 0001107421

Track this companyFree. Adds Alaunos Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials251 recruiting or active

Pipeline programs32From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline32

CarboplatinPhase 3 · Extensive-Stage Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
doxorubicinPhase 3 · Soft Tissue SarcomaClinicalTrials.gov · fetched Nov 12, 2026
EtoposidePhase 3 · Extensive-Stage Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Palifosfamide-trisPhase 3 · Extensive-Stage Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Palifosfamide-TrisPhase 3 · Soft Tissue SarcomaClinicalTrials.gov · fetched Nov 12, 2026
Ad-RTS-hIL-12Phase 2 · Pediatric Brain TumorClinicalTrials.gov · fetched Nov 12, 2026
Ad-RTS-hIL-12Phase 2 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
Ad-RTS-hIL-12Phase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
Ad-RTS-hIL-12 and VeledimexPhase 2 · Breast Cancer Nos Metastatic RecurrentClinicalTrials.gov · fetched Nov 12, 2026
Aldesleukin (IL-2)Phase 2 · Gynecologic CancerClinicalTrials.gov · fetched Nov 12, 2026
Cemiplimab-RwlcPhase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
DarinaparsinPhase 2 · Hematologic NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
DarinaparsinPhase 2 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
DarinaparsonPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
INXN-1001Phase 2 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
INXN-2001Phase 2 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
Neoantigen specific TCR-T cell drug productPhase 2 · Gynecologic CancerClinicalTrials.gov · fetched Nov 12, 2026
Oral Veledimex - Arm 1 (Pediatric Brain Tumor)Phase 2 · Pediatric Brain TumorClinicalTrials.gov · fetched Nov 12, 2026
Oral Veledimex - Arm 2 (DIPG)Phase 2 · Pediatric Brain TumorClinicalTrials.gov · fetched Nov 12, 2026
PalifosfamidePhase 2 · Breast Cancer Nos Metastatic RecurrentClinicalTrials.gov · fetched Nov 12, 2026
VeledimexPhase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
VeledimexPhase 2 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
ZIO-201Phase 2 · Advanced SarcomaClinicalTrials.gov · fetched Nov 12, 2026
capecitabinePhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
erlotinibPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
indibulinPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
indibulinPhase 1 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
IndibulinPhase 1 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
NivolumabPhase 1 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
palifosfamide-trisPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
palifosfamide-trisPhase 1 · MalignancyClinicalTrials.gov · fetched Nov 12, 2026
ZIO-101-C (Darinaparsin)Phase 1 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials25

Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRsCOMPLETED · started Oct 7, 2022ClinicalTrials.gov NCT05292859 · fetched Nov 12, 2026
Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid TumorsPHASE1_PHASE2 · TERMINATED · started Apr 4, 2022ClinicalTrials.gov NCT05194735 · fetched Nov 12, 2026
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid TumorsTERMINATED · started Oct 7, 2021ClinicalTrials.gov NCT05124743 · fetched Nov 12, 2026
Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive GlioblastomaPHASE2 · TERMINATED · started Aug 1, 2019ClinicalTrials.gov NCT04006119 · fetched Nov 12, 2026
Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102PHASE1 · COMPLETED · started Sep 5, 2018ClinicalTrials.gov NCT03679754 · fetched Nov 12, 2026
A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102PHASE1 · COMPLETED · started Jun 18, 2018ClinicalTrials.gov NCT03636477 · fetched Nov 12, 2026
A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPGPHASE1_PHASE2 · TERMINATED · started Sep 26, 2017ClinicalTrials.gov NCT03330197 · fetched Nov 12, 2026
A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Breast CancerPHASE1_PHASE2 · TERMINATED · started Jul 18, 2015ClinicalTrials.gov NCT02423902 · fetched Nov 12, 2026
Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.PHASE2 · TERMINATED · started Apr 4, 2013ClinicalTrials.gov NCT01703754 · fetched Nov 12, 2026
Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study)PHASE3 · TERMINATED · started Jun 8, 2012ClinicalTrials.gov NCT01555710 · fetched Nov 12, 2026
Long-Term Follow-Up of Recipient of Gene Transfer ResearchRECRUITING · started Dec 9, 2011ClinicalTrials.gov NCT01492036 · fetched Nov 12, 2026
Safety Study of Adenovirus Vector Engineered to Express hIL-12 in Combination With Activator Ligand to Treat MelanomaPHASE1_PHASE2 · COMPLETED · started Aug 1, 2011ClinicalTrials.gov NCT01397708 · fetched Nov 12, 2026
Effect on QTc, Pharmacokinetics, Safety, and Preliminary Efficacy of Single-agent Palifosfamide-tris in Subjects With Advanced Solid TumorsPHASE1 · COMPLETED · started Jun 1, 2011ClinicalTrials.gov NCT01340547 · fetched Nov 12, 2026
Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With MalignanciesPHASE1 · COMPLETED · started Dec 1, 2010ClinicalTrials.gov NCT01242072 · fetched Nov 12, 2026
Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue SarcomaPHASE3 · TERMINATED · started Aug 16, 2010ClinicalTrials.gov NCT01168791 · fetched Nov 12, 2026
Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast CancerPHASE1 · TERMINATED · started Apr 6, 2010ClinicalTrials.gov NCT01113970 · fetched Nov 12, 2026
A Study of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Unresectable or Metastatic Soft-tissue SarcomaPHASE2 · TERMINATED · started Sep 3, 2008ClinicalTrials.gov NCT00718484 · fetched Nov 12, 2026
Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid TumorsPHASE1 · TERMINATED · started Jun 19, 2008ClinicalTrials.gov NCT00726687 · fetched Nov 12, 2026
Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid TumorsPHASE1 · COMPLETED · started Jan 1, 2008ClinicalTrials.gov NCT00591383 · fetched Nov 12, 2026
Phase I Study of Oral Darinaparsin (ZIO-101-C)in Advanced Solid Tumors and Non-Hodgkin's LymphomasPHASE1 · COMPLETED · started Aug 1, 2007ClinicalTrials.gov NCT00591422 · fetched Nov 12, 2026
Phase I Study in Advanced Solid TumorsPHASE1 · COMPLETED · started Jul 2, 2007ClinicalTrials.gov NCT00591292 · fetched Nov 12, 2026
A Phase-II Trial of ZIO 101 in Advanced Hepatocellular CarcinomaPHASE2 · TERMINATED · started May 1, 2007ClinicalTrials.gov NCT00423306 · fetched Nov 12, 2026
A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001bPHASE2 · COMPLETED · started Jan 1, 2007ClinicalTrials.gov NCT00423644 · fetched Nov 12, 2026
Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow CancersPHASE2 · TERMINATED · started Dec 29, 2006ClinicalTrials.gov NCT00421213 · fetched Nov 12, 2026
Study of ZIO-201 in Advanced SarcomaPHASE1_PHASE2 · COMPLETED · started Feb 21, 2006ClinicalTrials.gov NCT00439686 · fetched Nov 12, 2026

SEC filings12

8-K · 8-KSEC EDGAR · filed Oct 23, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Oct 21, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Oct 13, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Oct 9, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Sep 22, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Sep 17, 2026 · fetched Nov 12, 2026
10-Q · 10-QSEC EDGAR · filed Aug 14, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Jun 29, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed May 26, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed May 18, 2026 · fetched Nov 12, 2026
10-Q · 10-QSEC EDGAR · filed May 15, 2026 · fetched Nov 12, 2026
10-K/A · 10-K/ASEC EDGAR · filed Apr 30, 2026 · fetched Nov 12, 2026